Wanbury's Q1 PAT up 5.62 times at Rs 9.5 cr

Pharma major, Wanbury's net profit has grown 5.62 times at Rs 9.48 crore in Q1FY10 as against Rs 1.43 crore in the year-ago period.

Its net sales at Rs 83.74 crore in the reporting quarter rose 25.6 per cent as against Rs 66.66 crore in the year-ago period, a press release issued here today said.

EBITDA margin for Q1FY10 was at 19.60 per cent as against 16.40 per cent in Q1FY09.

Wanbury has registered a compounded annual growth rate of 68 per cent over the last 6-years and has a strong presence in domestic formulations, active pharmaceutical ingredients and contract research and manufacturing services (CRAMS), the release said.